The invention relates to a surgical device and method, and more particularly, a device and method for engagement to biological tissue during deployment of anastomotic clip or other securements.
Surgical procedures for connecting an anastomotic prosthesis to biological tissue, such as a blood vessel and the heart, have required manually suturing the prosthesis to the tissue. Manual suturing can be difficult due to limited access to, location of, and/or type of tissue. As an alternative or a compliment to manual suturing, an applicator tool can be used to deploy clips, sutures, and/or other types of securement for connecting the prosthesis to the tissue. The applicator tool can be used during minimally invasive surgery. During one type of minimally invasive surgery, a small hole or port may be created through the patient's body to give the surgeon access from outside of the body into a body cavity. The surgeon can have limited visibility of the target site and limited space for operation. Thus, the applicator tool can help to connect the surgeon to this target site and provide a constant connection with the target site to perform the targeted procedure.
When using an applicator tool, tissue may shift in position and/or move away from the applicator tool, which makes it difficult to accurately place the prosthesis at the desired location and to deploy the securement into the tissue. For example, when the tissue is a blood vessel or the heart, pulsatile blood flow may cause the tissue to shift in position. Even when blood flow is temporarily blocked or bypassed, the wet and slippery tissue may be pushed away instead of being pierced by the securement being deployed by the applicator tool. Even if surrounding tissue is secured, such as with temporary sutures, to a fixed structure like a surgical bed or a sternum retractor used to hold open the chest cavity, the tissue and applicator tool may still move relative to each other while the applicator tool is held by the surgeon. Relative movement between the tissue and applicator tool can cause inaccurate deployment of securement by the applicator tool.
There is a continuing need to make the procedure for connecting a prosthesis to tissue easier and faster to perform. There is also a need to engage an applicator tool to tissue during deployment of securement by an applicator tool.
Briefly and in general terms, the present invention is directed a coupling system and method for connecting an anastomotic prosthesis to tissue.
In aspects of the present invention, a system comprises an applicator tool configured to deploy a securement into an anastomotic prosthesis and tissue, and an engagement device attached to the applicator tool and configured to selectively engage and disengage the applicator tool to tissue.
In other aspects, the engagement device is configured to engage the tissue with application of suction to the engagement device, and is configured to disengage the tissue with removal of the suction.
In other aspects, the engagement device includes a plurality of contact members, each contact member including a concave wall, the concave wall having an aperture through which suction can be applied.
In other aspects, the engagement device includes a fluid conduit coupled to the apertures through which suction can be applied.
In other aspects, the engagement device includes a coupling member to which the contact members are attached, the coupling member sized to receive a forward segment of the applicator tool.
In other aspects, the coupling member is slideably coupled to the forward segment of the applicator tool.
In other aspects, the system further comprises an attachment ring for connecting an artificial conduit to a hollow anatomical organ.
In other aspects, the attachment ring is configured to connect an inflow conduit of a ventricular assist device to a heart.
In other aspects, the applicator tool includes a connector mechanism configured to selectively hold and release the attachment ring, and the applicator tool is configured to deploy the securement into the attachment ring.
In other aspects, the securement is a clip having a sharp tip for piercing the tissue.
In aspects of the present invention, a method comprises applying suction to an engagement device attached to an applicator tool. The applicator tool is configured to deploy a securement into an anastomotic prosthesis and the tissue. The method further comprises deploying the securement into the anastomotic prosthesis and the tissue during the applying of the suction to the engagement device.
In other aspects, the method further comprises removing the suction from the engagement device after the deploying of the securement, wherein the applying of the suction causes the engagement device to engage the tissue, and the removing of the suction causes the engagement device to disengage the tissue.
In other aspects, the applying of the suction to the engagement device includes applying the suction to a plurality of contact members disposed on the tissue, each contact member including a concave wall, the concave wall having an aperture through which suction is applied.
In other aspects, the suction is applied through a fluid conduit coupled to the apertures.
In other aspects, the method further comprises placing a forward segment of the applicator tool in a coupling member, the contact members being attached to the coupling member.
In other aspects, the method further comprises adjusting an axial position of the contact members by sliding the coupling member on the forward segment of the applicator tool.
In other aspects, the anastomotic prosthesis is an attachment ring for connecting an artificial conduit to a hollow anatomical organ, and the method further comprises positioning the attachment ring on the hollow anatomical organ before applying the suction to the engagement device.
In other aspects, the method further comprises connecting an inflow conduit of a ventricular assist device to the attachment ring.
In other aspects, the positioning of the attachment ring on the tissue is performed while the attachment ring is mounted on the applicator tool, and the method further comprises releasing the attachment ring from the applicator tool after the deploying of the securement.
In other aspects, the securement is a clip having a sharp tip for piercing the tissue.
The features and advantages of the invention will be more readily understood from the following detailed description which should be read in conjunction with the accompanying drawings.
As used herein, the term “anastomosis” refers to the interconnection of two hollow structures, any of which can be an artificial tubular conduit, a blood vessel, a heart, or other hollow anatomical organ. For example and without limitation, anastomosis can be performed to connect an inflow conduit of a ventricular assist device (VAD) to the ventricular apex of the heart. Various types of VADs are known in the art and need not be discussed herein. A feature or structure modified by the term “anastomotic” means that the feature or structure relates to or is used during interconnection of two hollow structures.
As used herein, any term of approximation such as, without limitation, near, about, approximately, substantially, essentially and the like mean that the word or phrase modified by the term of approximation need not be exactly that which is written but may vary from that written description to some extent. The extent to which the description may vary will depend on how great a change can be instituted and have one of ordinary skill in the art recognize the modified version as still having the properties, characteristics and capabilities of the modified word or phrase. For example and without limitation, a first structure that is described as “substantially parallel” in reference to a second structure encompasses an orientation that is perfectly parallel and an orientation that one skilled in the art would readily recognize as being parallel even though distances between corresponding locations on the two respective structures are not exactly the same.
As used herein, a “through-hole” refers to a lumen that extends from one surface of a structure completely through the structure to another surface of the structure such that, if desired, a fluid could pass completely through the structure.
Referring now in more detail to the exemplary drawings for purposes of illustrating embodiments of the invention, wherein like reference numerals designate corresponding or like elements among the several views, there is shown in
Attachment ring 30 has bottom end 32 and top end 34. Bottom end 32 is secured to biological tissue and top end 34 is configured to engage forward segment 12 of applicator tool 10. In some embodiments, attachment ring 30 includes features configured to connect with a conduit, such as an inflow conduit of a ventricular assist device (VAD), after attachment ring 30 has been secured to biological tissue, such as the ventricular apex of the heart. Methods for securing an inflow conduit to the ventricular apex by means of an attachment ring are described in U.S. Application Publication Nos. 2011/0118766 A1, 2011/0118833 A1, and 2011/0118829 A1, which are incorporated herein by reference for all purposes.
In use, attachment ring 30 is engaged to and carried by connector mechanism 26 at forward segment 12 of applicator tool 10. The user positions forward segment 12 at the desired location on biological tissue where attachment ring 30 is to be secured. The user actuates the various controls on applicator tool 10 to simultaneously deploy multiple clips, or other type of anastomotic securements, that secure attachment ring 30 to the tissue and to disconnect connector mechanism 26 from attachment ring 30.
In some embodiments, when the user actuates clip deployment handle 18, clips are pushed out of applicator tool 10 such that the tips of clips pass through attachment ring 30 and into underlying tissue. The tips initially move downward in a substantially straight trajectory into the tissue. Thereafter, each tip follows a curved trajectory that extends radially outward and away from attachment ring 30 and returns upward out of the tissue. The tips then turn downward and return toward attachment ring 30 and stop at a position adjacent to or on an outer surface of attachment ring 30. Thus it will be understood that during deployment out of applicator tool 10, the clips pass through and curl back toward attachment ring 30. As the user continues to pull clip deployment handle 18, a portion of attachment ring 30 clamps down onto or traps the tips, and prevents the tips from moving backwards into the tissue. Next, as the user actuates cinching handle 22, the rear segment of each clip is pulled up away from the tissue and into applicator tool 10. Since the tip of each clip is held in place by attachment ring 30, pulling the rear segment of each clip causes the middle segment of each clip to cinch or tighten against the tissue. This tightening of the clips increases engagement between the tissue and attachment ring 30. When the user actuates release knob 23, the rear segment of each clip is released from applicator tool 10. Features on each clip and attachment ring 30, such as protrusions and catch features, prevent the rear segment of each clip from slipping or moving down toward the tissue, which maintains the cinched or tightened state of the clips. When the user actuates disengagement knob 24, attachment ring 30 is released by connector mechanism 26 of applicator tool 10, which allows applicator tool 10 to be pulled away from the tissue while attachment ring 30 remains attached to the tissue.
In use, engagement device 700 is fitted around and engaged to forward segment 12 of applicator tool 10. Engagement device 700 is configured to temporarily engage forward segment 12 of applicator tool 10 to biological tissue to facilitate accurate positioning of attachment ring 30 to the tissue and to facilitate deployment of clips into the tissue. Engagement device 700 is configured to selectively engage onto and disengage from the tissue with the application and removal of suction. Engagement device 700 is set to engage onto tissue, with application of suction, when clips are deployed and cinched by applicator tool 10. Engagement device 700 is set to disengage from the tissue, with a partial decrease or complete removal of suction, after the clips are deployed and before applicator tool 10 is pulled away from the tissue and attachment ring 30.
As shown in
Fluid conduit 704 is a tube that extends from top or rear end 710 (
Fluid conduit 704 includes rear tube 704a, ring tube 704b, and a plurality of forward tubes 704c. Rear tube 704a is configured to be connected to a negative pressure source or suction pump. An end of rear tube 704a is connected to ring tube 704b which is connected to ends of forward tubes 704c. The opposite end of forward tubes 704c are connected to suction apertures 712 (
Coupling member 706 is in the shape of a tube and has central lumen 714. Central lumen 714 is sized to receive forward segment 12 of applicator tool 10. Six contact members 702 are arranged circumferentially around central lumen 714 at substantially equal circumferential spacing of about 60 degrees. In other embodiments, an engagement device can include a lesser or greater number of contact members 702.
Referring to
As shown in
As shown in
In some embodiments, concave walls 703 may be made of a flexible material, such as silicone rubber, to facilitate formation of a seal between peripheral edge 705 and the surface of tissue. As negative pressure builds in the cavity between concave walls 703 and the tissue surface, concave walls 703 may tend to collapse toward the tissue surface. Such collapse may result in deformation of peripheral edges 705 that causes loss of the air seal between peripheral edges 705 and the tissue. Also, if suction aperture 712 contacts tissue surface, suction and thus the area of tissue surface engagement will be limited to the area immediately surrounding suction aperture 712. Protrusions 720 are configured to help maintain the air seal and to prevent suction aperture 712 from contacting the tissue surface so that the area of tissue surface engagement extends out to peripheral edges 705 of contact members 702.
In some embodiments, protrusions 720 are configured to provide frictional engagement against the tissue surface. As negative pressure builds in the cavity between concave walls 703 and the tissue surface, concave walls 703 may tend to collapse toward the tissue surface so that protrusions 720 presses against and frictionally engage the tissue surface.
The clips for anchoring attachment ring 30 to biological tissue are contained within forward segment 12 of applicator tool 10. The configuration of each clip can be as shown in
When loaded inside applicator tool 10, curved segment 41 is in a straightened configuration. When deployed out of applicator tool 10, tip 44 will initially follow a straight path through attachment ring 30 and into the biological tissue. As curved segment 41 exits applicator tool 10, curved segment will autonomously return to a curved configuration, which causes tip 44 to follow a curved path beneath the tissue surface. Due to the curved path, tip 44 exits the tissue surface and loops back toward attachment ring 30. Attachment ring 30 includes features that clamp and/or trap tip 44. As tip 44 exits the tissue surface, annular surface 718 (
In some embodiments, band 742 of connector 740 is fixedly attached to forward segment 12 of applicator tool 10 with no ability to adjust the axial position of contact members 702 of engagement device 700 relative to forward segment 12 and attaching ring 30. In other embodiments, band 742 is slideably attached to forward segment 12 to allow a medial practitioner to selectively adjust and fix the axial position of contact members 702 relative to forward segment 12 and attachment ring 30.
In use, attachment ring 30 (not shown in
In other embodiments, engagement device 800 is combined with all the features of engagement device 700 such that coupling member 706 is replaced by suction cap 802. Alternatively, coupling member 706 can be fitted over and attached onto suction cap 802. Suction can be applied to contact members 702 and/or suction cap 802 to engage applicator tool 10 to tissue. Applying suction to contact members 702 helps to stabilize areas of tissue spaced apart from and surrounding attachment ring 30. Applying suction to suction cap 802 helps to stabilize areas of tissue directly beneath attachment ring 30. While negative pressure is generated within contact members 702 and/or suction cap 802, clips 36 are deployed out of applicator tool 10 and into the underlying tissue.
During a surgical procedure, engagement device 700, 800 and applicator tool 10 are fixed to each other. Applicator tool 10 is hand held by the surgeon who manipulates controls on the applicator tool. As the surgeon places applicator tool 10 at the target tissue, engagement device 700, 800 will engage surrounding tissue with application of suction and thereby prevent or minimize relative movement between applicator tool 10 and the target tissue. Engagement device 700, 800 is not fixedly connected to a surgical bed, sternum retractor, or other stationary structure. Engagement device 700, 800 does not fix or stabilize the surrounding tissue relative to a stationary structure. Engagement device 700, 800 fixes or stabilizes the surrounding tissue relative to applicator tool 10, which moves under the direction of the clinician. Thus, after engagement device 700, 800 attaches to surrounding tissue with suction, and if the clinician manually moves applicator tool 10 left, right, up or down within the patient's body cavity, applicator tool 10 will remain stationary relative to the target tissue. Applicator tool 10 will also remain at the target tissue even if the target tissue moves due to pulsatile blood flow, unexpected change in the patient's body position, or other reason. Thus it will be understood that applicator tool 10 and engagement device 700, 800 are designed to move with the target tissue and not to slip relative to the target tissue. Engagement device 700, 800 enables applicator tool 10 to be “stuck” with the target tissue, which helps to deploy the clips at the precise location selected by the surgeon. If desired, suction can be partially decreased or completely removed to allow the surgeon to adjust the position of applicator tool 10 on the tissue.
As discussed above, negative pressure or suction is applied to the engagement device 700, 800 so that engagement device 700, 800 attaches to the target tissue. A particular amount of negative pressure is necessary for the purpose of deploying the clips with consistency from applicator tool 10. Inconsistent clip deployment may take the form of undue variation in depth, direction, and/or curvature in the path of travel of the clips. The amount of negative pressure needed for consistent clip deployment may depend on multiple factors, including but not limited to the number of clips being deployed, the type of tissue into which the clips are being deployed, and the size of the surface area to which vacuum is being applied. A method according to the invention can include the steps discussed above in combination with either one or both of (1) the step of selecting or determining an amount of negative pressure that corresponds to a threshold level of security between the applicator tool and the target tissue, and (2) the step of applying the preselected or predetermined amount of negative pressure to the engagement device 700, 800 during clip deployment. In various embodiments, the determined amount of negative pressure is selected to be below a maximum threshold. The maximum threshold may be selected to reduce the risk of injury to the target tissue.
Engagement device 700, 800 can be used for locating and targeting the site for attaching a VAD inflow conduit during an off-pump, minimally invasive surgical procedure as opposed to a conventional, open heart procedure. The term “off-pump” means that clip deployment is performed while the heart is beating and without a heart-lung or cardiopulmonary bypass procedure being performed. For example and without limitation, applicator tool 10 and engagement device 700, 800 can be introduced into the chest cavity of a patient via an intercostal approach or via a small incision between the ribs of the patient. In this example, a sternotomy and spreading of the left and right rib cage apart are avoided. After introduction into the chest cavity, the clinician can place applicator tool 10 on the ventricular apex of the heart (the target tissue) and apply a sufficient amount of negative pressure to engagement device 700, 800 that substantially prevents relative movement between the target tissue and applicator tool 10.
Engagement device 700, 800 applies preset or adjustable force loading between the applicator tool 10 and the tissue. This loading is important for the success of deploying the clips. When applicator tool 10 is used in concert with engagement device 700, 800, and as a vacuum is applied, applicator tool 10 is pressed downward (as a result of the suction) against the tissue. The downward force (also referred to as load) applied by applicator tool 10 on the tissue depends upon a connection device that connects engagement device 700, 800 and applicator tool 10 together. The exemplary connection device allows for control of the amount of force on the tissue so that the force is simultaneously (1) below a maximum level that would damage the tissue, and (2) at or above a minimum level needed to ensure that the clips are properly deployed without undue variation in depth, direction, and/or curvature in the path of travel of the clips. Control of the amount of force on the tissue can be accomplished by adjusting the distance between the forward tip of attachment ring 30 and the base (736 in
Engagement device 700, 800 keeps the deployment site clear of possible obstruction. Engagement device 700, 800 completely engages the tissue area required for clip deployment and prevents surrounding tissue and other surgical devices from entering into that tissue area and interfering with clip deployment.
Engagement device 700 has contact members 702 that function as individual pods or feet that provide suction to discrete areas of tissue surrounding a central area into which clips are deployed. The central area is referred to as the clip deployment site. The discrete areas of tissue can be separated from each other by areas of tissue which receive no suction. Engagement device 800 has suction cap 802 that provides suction to a circular area that includes the clip deployment site.
As shown in
As shown in
The orientation and shape of the suction ports serve multiple purposes. Angle A1 is selected to allow for easy attachment of engagement device 700 to the heart. Angle A1 allows engagement device 700 to conform to the curved outer surface 734 of the heart. Angle A1 can be within the range of about 10 degrees to about 80 degrees, or more narrowly within the range of about 20 degrees to about 70 degrees, or at about 60 degrees. The appropriate angle depends in part on the physical size of the patient's heart. A relatively small angle would be more suitable for the curved outer surface of a relatively small heart, and a relatively large angle would be more suitable for the curved outer surface of a relatively large heart.
The orientation and shape of the suction openings will remodel the clip deployment site for engagement with applicator tool 10 and attachment ring 30. The configuration of the suction openings will pull the heart tissue 734 up to form an ideal shape for engagement with applicator tool 10 and attachment ring 30. The slanted angle of the engagement device surface in contact with the heart tissue 734, in combination with the vacuum suction, will change the shape of the heart so it can conform to that of the engagement device and/or attachment ring 30.
The orientation and shape of the suction openings minimize the movement of the tissue during clip deployment.
The angular orientation of the suction opening, Angle A1, can be adjusted according to the surgeon's need. Contact members 702 are adjustable and designed to contour to the shape of the outer surface of the heart. Making joint 708 (
An engagement device can have an annular or ring-shaped contact member 750, as shown in
Interior surface 760 is oriented at acute Angle A2 relative to central axis 762. Angle A2 can be about 25 degrees. In other embodiments, Angle A2 can be within the range of about 10 degrees to about 80 degrees, or more narrowly within the range of about 20 degrees to about 70 degrees, or at about 60 degrees. Angle A2 is selected with the purpose of maintaining contact with the heart surface which is not flat, but curved so that ring-shaped contact member 750 can “cup” the heart.
Contact member 750 includes multiple attachment points 764 (
As shown in
In other embodiments, engagement device 700, 800 has attachment points around the outer perimeter of the device. The attachment points are configured to receive and retain add-on devices, such as a viewing port or a light source. The attachment points can be the same as or similar to accessory attachment points 770 described in connection with
While several particular forms of the invention have been illustrated and described, it will also be apparent that various modifications can be made without departing from the scope of the invention. It is also contemplated that various combinations or subcombinations of the specific features and aspects of the disclosed embodiments can be combined with or substituted for one another in order to form varying modes of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.
This application claims the benefit of U.S. Provisional Application No. 61/636,889, filed Apr. 23, 2012, which is incorporated herein by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
5158563 | Cosman | Oct 1992 | A |
5291179 | Ooe et al. | Mar 1994 | A |
5582616 | Bolduc et al. | Dec 1996 | A |
5814005 | Barra et al. | Sep 1998 | A |
5827316 | Young et al. | Oct 1998 | A |
6079414 | Roth | Jun 2000 | A |
6080173 | Williamson, IV et al. | Jun 2000 | A |
6113611 | Allen et al. | Sep 2000 | A |
6193652 | Berky et al. | Feb 2001 | B1 |
6346071 | Mussivand | Feb 2002 | B1 |
6511416 | Green et al. | Jan 2003 | B1 |
6537300 | Girton | Mar 2003 | B2 |
6551332 | Nguyen et al. | Apr 2003 | B1 |
6607541 | Gardiner et al. | Aug 2003 | B1 |
6669708 | Nissenbaum et al. | Dec 2003 | B1 |
6689147 | Koster, Jr. | Feb 2004 | B1 |
6695859 | Golden et al. | Feb 2004 | B1 |
6699256 | Logan et al. | Mar 2004 | B1 |
6726648 | Kaplon et al. | Apr 2004 | B2 |
6732501 | Yu et al. | May 2004 | B2 |
6802806 | McCarthy et al. | Oct 2004 | B2 |
6824071 | McMichael | Nov 2004 | B1 |
6863677 | Breznock | Mar 2005 | B2 |
6942672 | Heilman et al. | Sep 2005 | B2 |
7077801 | Haverich | Jul 2006 | B2 |
7309343 | Vargas et al. | Dec 2007 | B2 |
7431727 | Cole et al. | Oct 2008 | B2 |
7510561 | Beane et al. | Mar 2009 | B2 |
7717844 | Cohn | May 2010 | B2 |
7744527 | Cohn | Jun 2010 | B2 |
7846123 | Vassiliades et al. | Dec 2010 | B2 |
7931581 | Cohn | Apr 2011 | B2 |
7942805 | Shambaugh, Jr. | May 2011 | B2 |
7993392 | Righini et al. | Aug 2011 | B2 |
8226670 | Beane et al. | Jul 2012 | B2 |
8556930 | Ellingwood | Oct 2013 | B2 |
20020045846 | Kaplon et al. | Apr 2002 | A1 |
20030023255 | Miles et al. | Jan 2003 | A1 |
20030130668 | Neiman et al. | Jul 2003 | A1 |
20040049194 | Harvie et al. | Mar 2004 | A1 |
20040087985 | Loshakove et al. | May 2004 | A1 |
20040092798 | Spence et al. | May 2004 | A1 |
20040102794 | Roy et al. | May 2004 | A1 |
20050187568 | Klenk et al. | Aug 2005 | A1 |
20050228410 | Berreklouw | Oct 2005 | A1 |
20050251209 | Saadat et al. | Nov 2005 | A1 |
20060036313 | Vassiliades et al. | Feb 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060089707 | Vassiliades et al. | Apr 2006 | A1 |
20060167333 | Moore et al. | Jul 2006 | A1 |
20070055357 | Pokorney et al. | Mar 2007 | A1 |
20070066943 | Prasad et al. | Mar 2007 | A1 |
20070106315 | Gregoric et al. | May 2007 | A1 |
20070112384 | Conlon et al. | May 2007 | A1 |
20070167964 | Willis | Jul 2007 | A1 |
20070167969 | Pandey | Jul 2007 | A1 |
20070197856 | Gellman et al. | Aug 2007 | A1 |
20070265643 | Beane et al. | Nov 2007 | A1 |
20080300628 | Ellingwood | Dec 2008 | A1 |
20090112062 | Bakos | Apr 2009 | A1 |
20090171136 | Shambaugh, Jr. | Jul 2009 | A1 |
20090204206 | Parquet et al. | Aug 2009 | A1 |
20090302089 | Harari et al. | Dec 2009 | A1 |
20100010500 | Beane et al. | Jan 2010 | A1 |
20100010538 | Juravic et al. | Jan 2010 | A1 |
20100161040 | Braido et al. | Jun 2010 | A1 |
20100168778 | Braido | Jul 2010 | A1 |
20100211082 | Sauer | Aug 2010 | A1 |
20110118766 | Reichenbach et al. | May 2011 | A1 |
20110118829 | Hoarau et al. | May 2011 | A1 |
20110118833 | Reichenbach et al. | May 2011 | A1 |
20120089181 | Shanley et al. | Apr 2012 | A1 |
20120165931 | Bourque | Jun 2012 | A1 |
20120221021 | Hoarau et al. | Aug 2012 | A1 |
Number | Date | Country |
---|---|---|
10 2004 047974 | Apr 2006 | DE |
1 691 884 | Mar 2011 | EP |
1 628 702 | May 2013 | EP |
WO 9603925 | Feb 1996 | WO |
WO 9625886 | Aug 1996 | WO |
WO 03001980 | Jan 2003 | WO |
WO 2006019755 | Feb 2006 | WO |
WO 2007038109 | Apr 2007 | WO |
WO 2008153872 | Dec 2008 | WO |
WO 2009100198 | Aug 2009 | WO |
WO 2013064529 | May 2013 | WO |
Entry |
---|
International Search Report for PCT/US2010/056751, mailed Oct. 7, 2011, 22 pgs. |
International Search Report for PCT/US2012/026838, mailed Aug. 10, 2012, 9 pgs. |
International Search Report for PCT/US2013/031279, mailed Jul. 10, 2013, 14 pgs. |
International Search Report and Written Opinion for PCT/US2014/029703, mailed Jul. 17, 2014, 14 pgs. |
Number | Date | Country | |
---|---|---|---|
20130282026 A1 | Oct 2013 | US |
Number | Date | Country | |
---|---|---|---|
61636889 | Apr 2012 | US |